Stonebridge Capital Advisors LLC Astrazeneca PLC Transaction History

Stonebridge Capital Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 23, 2023	SELL	$69.91 - $75.81 $40,198 - $43,590	-575 Reduced 91.56%	53 $3,000
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $3,346 - $3,794	53 Added 9.22%	628 $43,000
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $13,118 - $17,046	242 Added 72.67%	575 $38,000
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $1,431 - $3,665	27 Added 8.82%	333 $18,000
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $8,000 - $9,603	-135 Reduced 30.61%	306 $20,000
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $2,214 - $2,617	-41 Reduced 8.51%	441 $26,000
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $2,277 - $2,492	41 Added 9.3%	482 $29,000
Q2 2021 Aug 20, 2021	BUY	$48.42 - $60.18 $5,471 - $6,800	113 Added 34.45%	441 $26,000
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $15,468 - $17,856	328 New	328 $16,000
Q3 2020 Nov 18, 2020	SELL	$53.07 - $61.1 $19,158 - $22,057	-361 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $18,290 - $24,843	-484 Reduced 57.28%	361 $16,000
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $19,276 - $22,908	454 Added 116.11%	845 $42,000
Q2 2019 Aug 15, 2019	BUY	$37.28 - $41.68 $14,576 - $16,296	391 New	391 $16,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.